about
Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiencyThe innate immune system of the perinatal lung and responses to respiratory syncytial virus infectionSpecies-specific antagonism of host ISGylation by the influenza B virus NS1 protein.ISG15 in Host Defense Against Candida albicans Infection in a Mouse Model of Fungal Keratitis.The macrophage in HIV-1 infection: from activation to deactivation?A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway.Human rhinovirus-induced ISG15 selectively modulates epithelial antiviral immunity.Viral and host proteins that modulate filovirus buddingGenome-wide approaches to systematically identify substrates of the ubiquitin-proteasome pathwayInhibition of interferon induction and action by the nairovirus Nairobi sheep disease virus/Ganjam virus.Viral hijacking of the host ubiquitin system to evade interferon responses.Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:CCynoglossus semilaevis ISG15: a secreted cytokine-like protein that stimulates antiviral immune response in a LRGG motif-dependent manner.Camouflage and misdirection: the full-on assault of ebola virus diseaseMultiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcomeAntiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan Africa.Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiationModulation of the host interferon response and ISGylation pathway by B. pertussis filamentous hemagglutininIfih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.ISG15: leading a double life as a secreted molecule.Genomic and functional analysis of the host response to acute simian varicella infection in the lung.ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.Emerging roles for immunomodulatory functions of free ISG15.Interferon-stimulated gene 15 in hepatitis B-related liver diseases.Innate antiviral response: role in HIV-1 infection.Activation of endogenous type I IFN signaling contributes to persistent HCV infection.Crystal structure of human ISG15 protein in complex with influenza B virus NS1BAntiviral activity of salmonid gamma interferon against infectious pancreatic necrosis virus and salmonid alphavirus and its dependency on type I interferon.Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 to Regulate Egress.FAT10 Is Critical in Influenza A Virus Replication by Inhibiting Type I IFN.ISGylation governs the oncogenic function of Ki-Ras in breast cancer.Dugbe virus ovarian tumour domain interferes with ubiquitin/ISG15-regulated innate immune cell signallingISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.Porcine reproductive and respiratory syndrome virus nucleocapsid protein modulates interferon-β production by inhibiting IRF3 activation in immortalized porcine alveolar macrophages.Arenavirus buddingActivation of innate immune responses in the central nervous system during reovirus myelitis.Cell type-dependent regulation of free ISG15 levels and ISGylation.Budding of Enveloped Viruses: Interferon-Induced ISG15-Antivirus Mechanisms Targeting the Release Process
P2860
Q24294718-F01D0EBE-5203-41A4-A137-2C25C34ECFFBQ27011872-0E96077A-EF54-49D0-B23C-B8DD379C456BQ27865245-A98FBBE8-BE53-4AA3-9593-977C07D33CAAQ33792940-39697067-F4D7-4390-A142-E0E91B1DCE86Q33810779-97FCDBEC-B151-4507-801E-3BDC339759EDQ33813351-6B74BC63-43FC-40CD-AB7C-ECF4AAA0EA95Q34064995-3D0B3733-AC4B-4861-A3D1-1E7E65E2A668Q34070413-616DD879-4637-4224-9556-C8461AAB5AFDQ34079545-94AEA529-702E-4936-8FEB-3615039F4570Q34097947-1E36A12A-49D9-436A-96C6-DF105BCD2393Q34130663-66F89C03-9D85-4F88-9353-DA50AD01A6ECQ34251265-A188095B-DB42-4047-86F4-FBA0974D636FQ34427594-69A276E7-9A59-4B69-83B9-93E1C0E12F1AQ34449079-205A6BE6-79AD-4493-B1AB-755CF568244FQ34593105-39C85710-D643-494A-B374-E449F23B5E40Q35176322-A30E2D56-DCA0-41E4-8660-4F40FB7DEA97Q35560951-4124A180-FFD0-4F2B-98CF-FF8B2701AD0DQ35582662-6CFF5FAF-D0A8-4EA1-A291-026B04A5A68BQ35685720-7AFB54A3-1726-4938-B05D-FBD693919A2EQ35740189-9A8A3D49-BC01-4FA5-8DDC-46F6F777CEE0Q36401926-14CE1FF2-D055-44BE-9ED7-E04B468B7E3CQ36809721-9C2E7D9D-EE68-4D4B-BD14-8F8DBE60CA7BQ37291473-AA5AECA7-E8AE-4471-B21D-404E09D63A13Q37300449-57FED044-82A6-4DE4-A071-9796CB536731Q37404247-A8AFB99C-8EB5-4B37-A7FE-E0DC0477B175Q37708705-6E0DA4C7-ADB7-4A21-AC87-B0B58EEA6E3EQ37945237-0C6581CB-860D-4067-B097-B73DA7724567Q38210107-FBBEF96F-0E99-4F78-B8D2-B82F574C8FAAQ38263842-3916B464-D54D-439B-A817-355811355B1BQ38286184-80A1071F-F3DE-4ABC-82FF-F78AF71FFAB1Q38645983-2F7CB40A-EE53-4A11-96E4-AB98433730FAQ38761111-14F33E2A-DD80-495F-BC13-470B931E3AE0Q39210782-6488451E-9E9E-4A17-B44D-59B557DD2B73Q39247868-00AB945D-DA03-420A-8EBD-A59CB13C67C9Q39425033-E2A90FA7-2038-4E50-AC04-1922A0C42E9FQ39468134-F49B6E63-B5B3-4849-BB4D-999693A40BDDQ39543884-8C651AE0-D1E9-494E-88EA-ABD2F6BA9CDAQ41853710-B80FF6D1-FCC4-4A1A-971B-9260DC2267BCQ41865133-5424E703-3E32-4CF2-B118-2F6B4013414EQ42180882-929E6A66-1863-4802-809E-9180A2F5712B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiviral activity of innate immune protein ISG15.
@en
Antiviral activity of innate immune protein ISG15.
@nl
type
label
Antiviral activity of innate immune protein ISG15.
@en
Antiviral activity of innate immune protein ISG15.
@nl
prefLabel
Antiviral activity of innate immune protein ISG15.
@en
Antiviral activity of innate immune protein ISG15.
@nl
P2860
P921
P356
P1476
Antiviral activity of innate immune protein ISG15.
@en
P2093
Paula M Pitha
Ronald N Harty
P2860
P304
P356
10.1159/000226245
P577
2009-01-01T00:00:00Z